Učitavanje...
Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence
Psoriatic arthritis (PsA) is a chronic inflammatory arthropathy. Therapy with anti-tumor necrosis factor (TNF)-α agents represents the first therapeutic choice for moderate and severe forms; however, PsA patients can experience anti-TNFα failure, lack of efficacy, or adverse events. Several evidence...
Spremljeno u:
| Izdano u: | Drugs R D |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer International Publishing
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5694428/ https://ncbi.nlm.nih.gov/pubmed/29058302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-017-0215-7 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|